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Background: Exercise treadmill test (ETT) is an inexpensive and easily accessible non-invasive test. However it affords only modest sensitivity and 
specificity for ischaemic heart disease (IHD). Accordingly ETT can often provide results that are either equivocal or which run contrary to clinical 
suspicion. Therefore, clinicians frequently request an additional non-invasive test to clarify matters. Adenosine stress perfusion (CMR) has been 
shown to have a high sensitivity and specificity for the detection of IHD. We sought to evaluate a cohort of patients who had a recent ETT followed by 
stress perfusion CMR to examine the clinical utility of CMR in risk stratifying patients.
Methods: Analysis of patients referred for adenosine stress perfusion CMR in whom an ETT had been performed in the previous 3 months. Perfusion 
imaging was obtained at stress (adenosine 140 μg/kg/min) and rest on a 1.5T scanner. Late enhancement was assessed with dual pass gadolinium 
(total dose 0.2mmol/kg). Patient records, hospital databases and national death registries were reviewed. Major adverse cardiac events (MACE) 
comprising death, myocardial infarction, revascularisation or ischaemic hospitalisation were evaluated.
Results: Seventy patients (50% male, age 58.4 ±11.2 years), from a total of 362 stress perfusion scans, were identified between January 2008 
to May 2009. Twelve (17%) had a history of previous myocardial infarction or revascularisation. Seventeen had an objectively positive ETT, of which 
7 (41%) had a positive stress CMR. Thirty one had an equivocal ETT, of which 8 (26%) had a positive stress CMR. Twenty two had a negative ETT, of 
which 3 (14%) had a positive CMR. All positive CMRs had stenoses ≥50% at angiography, except for two patients (11%), both from the equivocal ETT 
group. A negative CMR, irrespective of ETT status, resulted in a 0% MACE rate at median 23 months (IQR 20-27) follow up. No positive CMRs were 
seen in negative or equivocal ETTs where ≥ 10 metabolic equivalents (METS) were attained.
Conclusions: Adenosine stress perfusion CMR can reliably risk stratify patients with recent indeterminate or equivocal ETT. A negative CMR is 
associated with an excellent prognosis at a median of 23 months follow up.
